Ajanta Pharma, a company engaged in manufacturing & marketing of pharmaceutical products, witnessed a rise in share price on Tuesday after the company announced that it has received final approval for its 3 ANDAs (Abbreviated New Drug Application) by US FDA (US Food & Drug Administration).

Montelukast Tablets, 10mg; Montelukast Sodium Chewable Tablets, 4mg & 5mg and Montelukast oral granules.

Shares of Ajanta Pharma are trading at Rs 1,630, up Rs 78.45, or 5.06% at the Bombay Stock Exchange (BSE) on Tuesday at 11:49 a.m.

The scrip has touched an intra-day high of Rs 1,648 and low of Rs 1,548.30. The total volume of shares traded at the BSE is 58,368.